Pablo Cano Trilla, Author at CBD-Intel

Inclusion of cannabis leaf extract in EU cosmetics database ‘a milestone’

Written by Pablo Cano Trilla || 25th November 2019 || Regulatory briefing |

Europe

Regulation and Legislation

Regulatory briefing

The inclusion of some new cannabis-related entries in the CosIng catalogue will facilitate the placement of cannabis-containing cosmetics in the EU market – provided all other rules, such as limits on THC, are respected ...

Small packet label exemptions: a guide to European CLP regulation, part 3

Written by Pablo Cano Trilla || 22nd November 2019 || Regulatory reports |

Europe

Regulation and Legislation

Regulatory reports

CBD-Intel examines possible exemptions for some small packages in EU regulations concerning classification, labelling and packaging (CLP)...

Toxicity and notifications: a guide to European CLP regulations, part 2

Written by Pablo Cano Trilla || 24th September 2019 || Regulatory reports |

Europe

Regulation and Legislation

Regulatory reports

This report continues to look at the European Union's CLP regulations and covers hazardous chemicals and obligations to notify, the part played by Poison Centres and the need for UFIs ...

Toxicity and notifications: a guide to European CLP regulations, part 1

Written by Pablo Cano Trilla || 24th September 2019 || Regulatory reports |

Europe

Regulation and Legislation

Regulatory reports

The EU’s Classification, Labelling and Packaging (CLP) Regulations classify all chemical substances and mixtures according to their toxicity levels. Part 1 of our report looks in detail at this legislation ...

California regulatory snapshot

Written by Pablo Cano Trilla || 7th May 2019 || Regulatory reports |

California

North America

United States

Regulation and Legislation

Regulatory reports

The sale of CBD, hemp extracts and flowers is legal in California, subject to a minimal regulatory burden, which CBD-Intel explains in detail in our first US state regulatory snapshot ...

European Commission differentiates CBD as cosmetic ingredient

Written by Pablo Cano Trilla || 10th April 2019 || Regulatory briefing |

Europe

Regulation and Legislation

Regulatory briefing

CBD’s entry in the European Commission’s database of cosmetics ingredients has been expanded to differentiate it from generic cannabis and by-products. The move offers more, but not total, clarity ...

Mexican regulatory body repeals guidelines amid confusion

Written by Pablo Cano Trilla || 29th March 2019 || Regulatory briefing |

Mexico

North America

Regulation and Legislation

Regulatory briefing

The Mexican Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) has changed its mind over the regulatory framework established for cannabis products in late 2018 ...

A guide to EU novel food rules for cannabinoid-containing edibles

Written by Pablo Cano Trilla || 26th March 2019 || Regulatory reports |

Europe

Policy and Politics

Regulatory reports

Under current EU rules, cannabinoid-containing hemp extracts could require pre-market authorisation as they are now considered to be novel foods. CBD-Intel explains how the rules work ...

How will Spanish elections change the outlook for CBD and cannabis?

Written by Pablo Cano Trilla || 26th February 2019 || Regulatory briefing |

Europe

Spain

Policy and Politics

Regulation and Legislation

Regulatory briefing

Whether the left or the right ends up in power – and that is difficult to predict – some form of debate around cannabis could be on the cards following forthcoming general elections in Spain ...

EU states could deem CBD, other cannabinoids illegal in cosmetics

Written by Pablo Cano Trilla || 21st February 2019 || Regulatory reports |

Europe

Regulation and Legislation

Regulatory reports

According to EU authorities, CBD and other cannabis extracts could be deemed illegal as an ingredient in cosmetics. However, individual member states have not made the same interpretation of the rules ...

Cannabis to be legalised? Mexico regulatory report

Written by Pablo Cano Trilla || 16th January 2019 || Regulatory reports |

Mexico

North America

Policy and Politics

Regulation and Legislation

Regulatory reports

Mexico may well become the third country in the world to fully legalise all cannabis products, including marijuana. In the meantime, CBD and hemp-containing products are allowed as long as they contain less than 1% THC ...

Are CBD edibles ‘novel food’? The EU debates this vital question

Written by Pablo Cano Trilla || 7th January 2019 || Regulatory reports |

Europe

Regulation and Legislation

Regulatory reports

The CBD industry is currently navigating a complex and changing regulatory landscape across the European Union. CBD-Intel brings some light to the obscure area of novel food regulation – and asks the vital questions ...

A highly restrictive regime: Australia regulatory report

Written by Pablo Cano Trilla || 29th November 2018 || Regulatory reports |

Australasia

Australia

Regulation and Legislation

Regulatory reports

Australia is a highly restrictive market for CBD, with limits on growing and extraction and an absolute prohibition on CBD in consumer products. This report details what is and what is not allowed ...

Italian enforcers issue stern ‘reminder’ – including CBD ban

Written by Pablo Cano Trilla || 18th May 2018 || Regulatory briefing |

Europe

Italy

Regulation and Legislation

Regulatory briefing

The Italian Customs and Monopolies Agency (AAMS) has issued a bulletin informing the country’s e-cigarette industry of its interpretation of legal requirements arising from the EU Tobacco Products Directive (TPD) ...

CBD as an ingredient in e-liquids:
EU regulatory report

Written by Pablo Cano Trilla || 9th May 2018 || Regulatory reports |

Europe

Regulation and Legislation

Regulatory reports

What laws regulate the use of cannabidiol (CBD) in e-liquids across the European Union – and what regulatory regime is likely to apply in the future? Our report finds the clear lines in a legal grey area ...

Written by Pablo Cano Trilla || 25th November 2019 || Regulatory briefing |

Written by Pablo Cano Trilla || 22nd November 2019 || Regulatory reports |

Written by Pablo Cano Trilla || 24th September 2019 || Regulatory reports |

Written by Pablo Cano Trilla || 24th September 2019 || Regulatory reports |

Written by Pablo Cano Trilla || 7th May 2019 || Regulatory reports |

Written by Pablo Cano Trilla || 10th April 2019 || Regulatory briefing |

Written by Pablo Cano Trilla || 29th March 2019 || Regulatory briefing |

Written by Pablo Cano Trilla || 26th March 2019 || Regulatory reports |

Written by Pablo Cano Trilla || 26th February 2019 || Regulatory briefing |

Written by Pablo Cano Trilla || 21st February 2019 || Regulatory reports |

Written by Pablo Cano Trilla || 16th January 2019 || Regulatory reports |

Written by Pablo Cano Trilla || 7th January 2019 || Regulatory reports |

Written by Pablo Cano Trilla || 29th November 2018 || Regulatory reports |

Written by Pablo Cano Trilla || 18th May 2018 || Regulatory briefing |

Written by Pablo Cano Trilla || 9th May 2018 || Regulatory reports |

Sign up to our newsletter

Subscribe for the latest industry updates

New Year Offer

Don't miss out